Stage II Breast Cancer: Elsa's Patient Story

Patient Info: Elsa | Stage II

Elsa said her breast cancer was in remission and continued anastrozole hormone therapy after lumpectomy, chemotherapy, and radiation.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Antonia's Survivor Story

Patient Info: Antonia, Female, Under 40 | Stage III

Antonia described herself as being in remission after multimodal treatment while continuing hormone therapy. Fear of recurrence and metastatic spread remained significant.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Mujer's Patient Story

Patient Info: Mujer Valiente | Stage III

Mujer Valiente remained on hormone therapy after selecting a multimodal treatment plan for stage 3 breast cancer.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Carlie's Patient Story

Patient Info: Carlie, Female, 50s | Stage III

As of 2022, Carlie was in remission after double mastectomy, lymphadenectomy, chemotherapy, and radiation therapy, while continuing hormone therapy and managing long-term side effects.

Our Cancer StoriesRead more →

Stage II Breast Cancer: April's Survivor Story

Patient Info: April, Female, Under 40 | Stage II

April described herself as being in remission in 2024 while continuing hormone therapy and targeted therapy. Emotional and financial effects remained nearly 2 years after diagnosis.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Carmen's Survivor Story

Patient Info: Carmen, Female, 50s | Stage III

Carmen was declared cancer-free in February 2023 after surgery and follow-up examinations, while continuing hormone therapy and pain medication.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Karol's Patient Story

Patient Info: Karol | Stage III

Karol continued hormone therapy for stage 3 breast cancer after a broader treatment plan including surgery, chemotherapy, and radiation had been recommended.

Our Cancer StoriesRead more →

Nelly

Patient Info: Nelly | Stage II

Nelly said she was in remission after completing active treatment and continued hormone therapy.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Veronica's Patient Story

Patient Info: Veronica | Stage III

Veronica had completed the other parts of her treatment plan and remained on hormone therapy while looking ahead to recovery and returning to work.

Our Cancer StoriesRead more →

Stage I Invasive Ductal Carcinoma: Paisley's Patient Story

Patient Info: Paisley | Stage I

She completed surgery and radiation and remained on hormone therapy more than a year after diagnosis.

Our Cancer StoriesRead more →

Breast Cancer: Mandy's Survivor Story

Patient Info: Mandy

Mandy said her doctor had declared the breast cancer in remission, and she continued hormone therapy.

Our Cancer StoriesRead more →

Stage III Breast Cancer: Katie's Survivor Story

Patient Info: Katie, Female, Under 40 | Stage III

Biomarkers: Hormone-sensitive breast cancer; specific receptor results not otherwise reported

As of December 2021, Katie had no evidence of cancer at the 5-year treatment mark after Stage III hormone-sensitive breast cancer treatment and later had twins after ovarian function returned.

Cleveland ClinicRead more →

Stage III Invasive Lobular Carcinoma: Jacque's Patient Story

Patient Info: Jacque, Female | Stage III

Jacque was treated for Stage III ILC with chemotherapy, 2 lumpectomies, daily radiation, and ongoing Tamoxifen as of December 2021.

Lobular Breast Cancer AllianceRead more →

Stage III Invasive Lobular Carcinoma: Martha's Survivor Story

Patient Info: Martha, Female, 40s | Stage III

Martha completed chemotherapy, bilateral mastectomies and 30 radiation treatments and remained on Tamoxifen as part of a planned 10-year course.

Lobular Breast Cancer AllianceRead more →

Stage III Invasive Lobular Carcinoma: Angie's Patient Story

Patient Info: Angie, Female | Stage III

Angie completed 4 AC, 12 Taxol, and 30 rounds of radiation for Stage III grade 3 ILC, then continued Arimidex for a planned 10 years as of September 2021.

Lobular Breast Cancer AllianceRead more →

Invasive Lobular Carcinoma: Maureen's Patient Story

Patient Info: Maureen, Female

Biomarkers: Breast Cancer Index test used to guide duration of anti-estrogen therapy

Maureen completed double mastectomy and 30 radiation treatments for pleomorphic ILC and planned 10 years of anti-estrogen therapy based on Breast Cancer Index testing.

Lobular Breast Cancer AllianceRead more →

Stage IV Invasive Lobular Carcinoma: Carol's Survivor Story

Patient Info: Carol, Female, 60s | Stage IV

Metastatic Site: Bone

Carol had de novo Stage IV breast cancer with bone metastases, achieved complete remission after chemotherapy, stayed on daily Letrozole for 10 years, then returned to NED/no active disease after Kisqali and Faslodex for bone progression.

Lobular Breast Cancer AllianceRead more →

Invasive Lobular Carcinoma: Susie's's Patient Story

Patient Info: Susie's daughter, Female, 40s

As of May 2021, Susie’s daughter was living after treatment for an 8 cm invasive lobular carcinoma and dealing with side effects from different endocrine therapies, while Susie became active in ILC advocacy and research support.

Lobular Breast Cancer AllianceRead more →

Male breast cancer discovered after years of stiff-person syndrome

Patient Info: Anonymized, Male, 50s

Biomarkers: ER-positive; PR-positive; HER2-negative; anti-amphiphysin antibody positive at 1:64; hereditary cancer panel negative for pathogenic germline variants.

He completed curative-intent breast cancer treatment and reported substantial improvement in upper-body stiffness, although lower-extremity stiffness, cramps, and unsteadiness persisted.

PubMed CentralRead more →

Breast cancer returned in the stomach and peritoneum after three years in remission

Patient Info: Anonymized, Female, 60s | Stage Metastatic/Advanced

Biomarkers: Initial breast tumor: ER 95%, PR 5%, HER2-negative, Nottingham grade 2. Metastatic peritoneal tumor: ER 80%

Metastatic Site: stomach; peritoneum

After metastatic breast cancer was confirmed in the stomach and peritoneum, she chose palliative care and inpatient hospice and died a few weeks later.

PubMed CentralRead more →

Breast cancer with sarcoidosis that mimicked metastatic disease

Patient Info: Anonymized, Female, 40s

Biomarkers: ER-positive; PR-positive; HER2-negative.

Her most recent mammogram showed no recurrent breast cancer while she continued letrozole, goserelin, and six-monthly follow-up.

PubMed CentralRead more →

Adenoid cystic cancer of the left breast treated with bilateral mastectomy and tamoxifen

Patient Info: Anonymized, Female, 60s

Biomarkers: BRCA1/2 negative for known pathogenic variants.

The left adenoid cystic carcinoma had not recurred, although a biologically distinct second primary later developed in right axillary ectopic breast tissue.

PubMed CentralRead more →

Breast cancer recurrence in the mandibular condyle causing jaw pain

Patient Info: Anonymized, Female, 50s | Stage IV

Biomarkers: ER-positive; PR-positive; HER2-negative.

Metastatic Site: right mandibular condyle with extension into the…

After anastrozole and 60 Gy of radiation, her jaw pain, mouth opening, and function improved, although some discomfort remained and palliative systemic treatment was continuing.

PubMed CentralRead more →

Recovery from severe bowel and oesophageal complications after breast cancer chemotherapy

Patient Info: Anonymized, Female, 40s

Biomarkers: HER2-positive.

She regained independence after an 89-day hospital course, but breast surgery remained deferred three months after intensive-care discharge and tamoxifen was being used during recovery.

PubMed CentralRead more →